Do you or someone you care for have a diagnosis of Alzheimer's Disease?
You (or the person you care for) may be eligible to participate in UCSD's study.
What Is The Study About?
This study will test the effects of memantine on dementia symptoms in older adults with mild to moderate Alzheimer's disease who are not currently taking Alzheimer's medications. Memantine, also known as Namenda, is approved by the U.S. Food and Drug Administration to treat moderate to severe symptoms of Alzheimer's disease.
Please answer the questions in this short survey. If you qualify, you will be contacted by study staff to discuss the study.
If you do not qualify, but would like to be notified of future research, please join our newsletter at the bottom of this page.
Reach out to the UCSD study team at 619-543-7840 or RPAlzheimersStudy@health.ucsd.edu